Embryoxite
Techstars '25Florida, US · 2 known investors
Embryoxite develops non-invasive, AI-powered embryo analysis that predicts IVF implantation success by analyzing spent culture medium, alongside an IVF electronic medical record platform (Nuvia) and an ovarian reserve assessment tool (OvAI). It serves fertility clinics and reproductive medicine specialists.
Founders & leadership
M
MarisaMetabolomics Specialist / Metabolome Advisor, PhD Chemistry